Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 3051–3100 of 34667
The Board of Directors of SINTX Technologies, Inc. (the “Company”) appointed Jay M. Moyes, Robert D. Mitchell, Mark Anderson, Chris Lyons and Gregg Honigblum to the Board of Directors of the Company, effective April 3, 2025.
The Board of Directors of SINTX Technologies, Inc. (the “Company”) appointed Jay M. Moyes, Robert D. Mitchell, Mark Anderson, Chris Lyons and Gregg Honigblum to the Board of Directors of the Company, effective April 3, 2025.
The Board of Directors of SINTX Technologies, Inc. (the “Company”) appointed Jay M. Moyes, Robert D. Mitchell, Mark Anderson, Chris Lyons and Gregg Honigblum to the Board of Directors of the Company, effective April 3, 2025.
The Board of Directors of SINTX Technologies, Inc. (the “Company”) appointed Jay M. Moyes, Robert D. Mitchell, Mark Anderson, Chris Lyons and Gregg Honigblum to the Board of Directors of the Company, effective April 3, 2025.
Dr. Adler was appointed as Chief Technology Officer and as a Board member of the Company
each of whom was a member of the board of directors of The First immediately prior to the Effective Time
each of whom was a member of the board of directors of The First immediately prior to the Effective Time
each of whom was a member of the board of directors of The First immediately prior to the Effective Time
each of whom was a member of the board of directors of The First immediately prior to the Effective Time
On April 4, 2025, the Board of Directors (the “ Board ”) of Amarin Corporation plc (the “ Company ”) appointed Michael Torok, 46, to the Board to a term commencing on such date.
his intent to retire from the Board at the expiration of his current term at the 2025 annual meeting of stockholders
Effective as of April 7, 2025, the board of directors (the “Board”) of MBX Biosciences, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the “NCG Committee”), appointed Steven L. Hoerter as a director of the Company.
Alan Pickerill resigned from the Board of Directors of the Company.
On April 7, 2025, the Board of Directors (the "Board") of Barrett Business Services, Inc. (the "Company") appointed Mark S. Finn, effective April 7, 2025, to serve until the Company's 2025 annual meeting of stockholders, at which time he is expected to stand for re-election.
On April 6, 2025, the Board of Directors (the “Board”) of Match Group, Inc. (the “Company”) adopted a resolution appointing Darrell Cavens to the Board
On April 3, 2025, John W. Cumming, David Elsbree, Robin Toft, Seymour Liebman and Laura Adams each notified the Company of their respective resignations as members of the Company’s Board and all committees thereof, effective as of 2;25 p.m on April 3, 2025.
On April 3, 2025, John W. Cumming, David Elsbree, Robin Toft, Seymour Liebman and Laura Adams each notified the Company of their respective resignations as members of the Company’s Board and all committees thereof, effective as of 2;25 p.m on April 3, 2025.
On March 31, 2025, John Sperzel and Robin Toft each notified T2 Biosystems, Inc. (the “Company”) of their respective resignations as members of the Company’s board of directors (the “Board”) and all committees thereof, effective immediately.
On April 3, 2025, John W. Cumming, David Elsbree, Robin Toft, Seymour Liebman and Laura Adams each notified the Company of their respective resignations as members of the Company’s Board and all committees thereof, effective as of 2;25 p.m on April 3, 2025.
On April 3, 2025, John W. Cumming, David Elsbree, Robin Toft, Seymour Liebman and Laura Adams each notified the Company of their respective resignations as members of the Company’s Board and all committees thereof, effective as of 2;25 p.m on April 3, 2025.
On March 31, 2025, John Sperzel and Robin Toft each notified T2 Biosystems, Inc. (the “Company”) of their respective resignations as members of the Company’s board of directors (the “Board”) and all committees thereof, effective immediately.
On April 3, 2025, the Board appointed Craig R. Jalbert, age 63, as a Class I director and the Company’s Chief Executive Officer, President, Corporate Treasurer, and Corporate Secretary, effective as of 11:30 a.m. on April 3, 2025.
On April 2, 2025, the Board of Directors (the “Board”) of Viridian Therapeutics, Inc. (the “Company”), appointed Jeff Ajer to serve as a Class I director of the Company, effective as of April 7, 2025.
Effective as of April 6, 2025, the Board elected each of Christine M. McCarthy, John Berisford and Rachel C. Glaser to serve on the Board.
Effective as of April 6, 2025, the Board elected each of Christine M. McCarthy, John Berisford and Rachel C. Glaser to serve on the Board.
Effective as of April 6, 2025, the Board elected each of Christine M. McCarthy, John Berisford and Rachel C. Glaser to serve on the Board.
Effective as of April 6, 2025, each of Michael R. Klein, Christopher J. Nassetta and Laura C. Kaplan tendered their resignations from the Board, all applicable Board committees and, for Mr. Klein, from his role as Chairman of the Board, effective as of the election of the New Independent Appointees.
Effective as of April 6, 2025, each of Michael R. Klein, Christopher J. Nassetta and Laura C. Kaplan tendered their resignations from the Board, all applicable Board committees and, for Mr. Klein, from his role as Chairman of the Board, effective as of the election of the New Independent Appointees.
Effective as of April 6, 2025, each of Michael R. Klein, Christopher J. Nassetta and Laura C. Kaplan tendered their resignations from the Board, all applicable Board committees and, for Mr. Klein, from his role as Chairman of the Board, effective as of the election of the New Independent Appointees.
On April 4, 2025, Rodney Adkins informed PayPal Holdings, Inc. (“PayPal” or the “Company”) that he will not stand for re-election to PayPal’s Board of Directors (“Board”) when his current term expires at PayPal’s 2025 Annual Meeting of Stockholders (“2025 Annual Meeting”).
On April 3, 2025, the board of directors (the “Board”) of Bowman Consulting Group Ltd. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee, appointed Virginia L. Grebbien to serve as a Class II director, effective as of such date
In addition, on April 2, 2025, Glenn P. Marino notified the Company of his decision to retire from the Board immediately following the 2025 Annual Meeting.
On April 1, 2025, in connection with the IPO, Neil Leibman, Warren Thompson, and David Perlin (collectively with Steve Salis and Jamie Karson, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On April 1, 2025, in connection with the IPO, Neil Leibman, Warren Thompson, and David Perlin (collectively with Steve Salis and Jamie Karson, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On April 1, 2025, in connection with the IPO, Neil Leibman, Warren Thompson, and David Perlin (collectively with Steve Salis and Jamie Karson, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On April 1, 2025, in connection with the IPO, Neil Leibman, Warren Thompson, and David Perlin (collectively with Steve Salis and Jamie Karson, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On April 1, 2025, in connection with the IPO, Neil Leibman, Warren Thompson, and David Perlin (collectively with Steve Salis and Jamie Karson, the “Directors”) were appointed to the board of directors of the Company (the “Board”).
On April 4, 2025, the Board elected each of Joseph Onorati, Marco Santori and Zachary Tai as directors of the Company, to fill the vacancies on the Board.
Effective as of April 4, 2025, Samuel Haskell, Marcelo Lemos and Ned Siegel resigned from the Board and, to the extent applicable, all committees thereof.
Effective as of April 4, 2025, Samuel Haskell, Marcelo Lemos and Ned Siegel resigned from the Board and, to the extent applicable, all committees thereof.
On April 4, 2025, the Board elected each of Joseph Onorati, Marco Santori and Zachary Tai as directors of the Company, to fill the vacancies on the Board.
On April 4, 2025, the Board elected each of Joseph Onorati, Marco Santori and Zachary Tai as directors of the Company, to fill the vacancies on the Board.
Effective as of April 4, 2025, Samuel Haskell, Marcelo Lemos and Ned Siegel resigned from the Board and, to the extent applicable, all committees thereof.
On April 1, 2025, the board of directors (the “Board”) of Rain Enhancement Technologies Holdco, Inc. (the “Company”), increased the size of the Board from five to seven directors and appointed Mr. Marcus Peperzak and Mr. Robert Reardon to the Board to fill the resulting vacancies.
On April 1, 2025, the board of directors (the “Board”) of Rain Enhancement Technologies Holdco, Inc. (the “Company”), increased the size of the Board from five to seven directors and appointed Mr. Marcus Peperzak and Mr. Robert Reardon to the Board to fill the resulting vacancies.
the Board appointed Andrew E. Holm and Paula Schaefer to serve as directors, with Ms. Schaefer serving as an independent director, effective as of April 3, 2025.
the Board appointed Andrew E. Holm and Paula Schaefer to serve as directors, with Ms. Schaefer serving as an independent director, effective as of April 3, 2025.
On April 3, 2025, Rajat Dhanda and Daniel J. Sullivan, each a member of the board of directors (the “Board”) of the Company, notified the Company of their decisions to step down from their positions on the Board, which resignations became effective on that day.
On April 3, 2025, Rajat Dhanda and Daniel J. Sullivan, each a member of the board of directors (the “Board”) of the Company, notified the Company of their decisions to step down from their positions on the Board, which resignations became effective on that day.
On April 1, 2025, the Board of Directors (the “ Board ”) of Braemar Hotels & Resorts Inc. (the “ Company ”) appointed Ms. Kellie Sirna to the Board, effective immediately, to serve until the next annual meeting of stockholders of the Company and until her successor is duly elected and qualified.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.